​

ImmunoPrecise Antibodies Ownership | Who Owns ImmunoPrecise Antibodies?

OverviewChartTranscripts

ImmunoPrecise Antibodies Ownership Summary

ImmunoPrecise Antibodies is owned by 12.08% institutional investors, 9.07% insiders, and 78.85% retail investors. Citadel advisors is the largest institutional shareholder, holding 0.02% of IPA shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.02% of its assets in ImmunoPrecise Antibodies shares.

IPA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockImmunoPrecise Antibodies12.08%9.07%78.85%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Citadel advisors5.08K0.02%$5.13K
Renaissance---
Two sigma securities---
Thoroughbred financial services---
Tower research capital llc (trc)---
Cibc world market---
Mariner---
Federation des caisses desjardins du quebec---
Baader bank aktiengesellschaft---
National bank of canada /fi/---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
National bank of canada /fi/---
Renaissance---
Mariner---
Thoroughbred financial services---
Tower research capital llc (trc)---
Cibc world market---
Two sigma securities---
Federation des caisses desjardins du quebec---
Baader bank aktiengesellschaft---
Geode capital management---

Top Buyers

HolderShares% AssetsChange
Citadel advisors5.08K-5.08K
Tower research capital llc (trc)---3.00
Citigroup---7.00
West paces advisors---1.67K
National bank of canada /fi/---1.67K

Top Sellers

HolderShares% AssetsChange
Ingalls & snyder---2.78M
Xtx topco---91.38K
Two sigma investments, lp---90.86K
Cibc world market---41.20K
Northern trust---41.11K

Sold Out

HolderChange
Tower research capital llc (trc)-3.00
Citigroup-7.00
West paces advisors-1.67K
National bank of canada /fi/-1.67K
Simplex trading-6.08K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025268.33%4,000,4861.76%128.43%1330.00%650.00%
Mar 31, 20252433.33%3,931,347106.15%1126.04%10150.00%433.33%
Dec 31, 2024185.88%1,906,9890.52%613.87%4-33.33%3-
Sep 30, 202417-19.05%1,897,10614.54%616.97%6-14.29%3-
Jun 30, 202421-19.23%1,656,275-0.97%614.40%7-12.50%3-40.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index10.67K0.02%-

IPA Ownership FAQ

Who Owns ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies shareholders are primarily institutional investors at 12.08%, followed by 9.07% insiders and 78.85% retail investors. The average institutional ownership in ImmunoPrecise Antibodies's industry, Biotech Stocks , is 45.24%, which ImmunoPrecise Antibodies falls below.

Who owns the most shares of ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies’s largest shareholders are Citadel advisors (5.08K shares, 0.02%), Renaissance (0 shares, 0%), and Two sigma securities (0 shares, 0%). Together, they hold 0.02% of ImmunoPrecise Antibodies’s total shares outstanding.

Does Blackrock own ImmunoPrecise Antibodies?

BlackRock is not among the top 10 institutional shareholders of ImmunoPrecise Antibodies.

Who is ImmunoPrecise Antibodies’s biggest shareholder by percentage of total assets invested?

National bank of canada /fi/ is ImmunoPrecise Antibodies’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 ImmunoPrecise Antibodies shares, valued at 0$.

Who is the top mutual fund holder of ImmunoPrecise Antibodies shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of ImmunoPrecise Antibodies shares, with 0.02% of its total shares outstanding invested in 10.67K ImmunoPrecise Antibodies shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools